At a glance
ClinicalIndex Comparison RecordN/ACompleted· 75,771 enrolled
Drug / intervention
Exposure of skin cancer of interestother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Incidence of Melanoma and Non-melanoma Skin Cancer in People With Vitiligo: A Case-control Study in the United Kingdom, 2009-2020
In Brief
An observational study evaluating Exposure of skin cancer of interest for Vitiligo and 5 related conditions. Completed, enrolled 75,771 participants across 1 site.
Detailed Summary
This study examines melanoma and nonmelanoma skin cancer in people diagnosed with vitiligo compared to matched controls.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsVitiligo, Melanoma (Skin), Nonmelanoma Skin Cancer, Squamous Cell Carcinoma, Basal Cell Carcinoma, Actinic Keratoses
CountriesUnited Kingdom
CollaboratorsPfizer
Timeline
N/ACompletedFinished
20222023202420252026
Enrollment StartJun 2021
First PostedJul 2021
Primary CompletionMar 2022
Study CompletionApr 2023
TodayJul 2026
First PostedJul 20, 2021
Enrollment StartJun 18, 2021
Primary CompletionMar 31, 2022
Study CompletionApr 4, 2023
TodayJul 2, 2026
Enrollment to primary: 9 monthsPosted 5.0 years ago
Interventions
Exposure of skin cancer of interestother
Melanoma and nonmelanoma skin cancers: squamous cell carcinoma, basal cell carcinoma and actinic keratoses.